Tag: Eculizumab

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Eculizumab

Patented Medicine Prices Review Board Issues a Notice of Hearing for Allegations of ...

Added to Collection on: 2024-04-02 19:40:49

Tags for this article:

Eculizumab
Immunosuppressants
Alexion Pharmaceuticals
Patented Medicine Prices Review Board
Medication
Atypical hemolytic uremic syndrome
Pricing
Pharmaceutical industry
Alexion Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
SOLIRIS by AstraZeneca expected to drive market size of Generalized Myasthenia Gravis

Added to Collection on: 2024-04-04 17:19:01

Tags for this article:

Orphan drugs
Eculizumab
Immunosuppressants
GMG
Myasthenia gravis
Gravis
Myasthenia
Market research
Germany
France
Japan
DelveInsight Business Research LLP
United States
Italy
United Kingdom
Soliris
AstraZeneca
Spain

Click the tags to see associated articles and topics

View Article Details
Long-Term Data Affirm Efficacy of Eculizumab in Refractory Generalized MG

Added to Collection on: 2024-04-15 20:56:51

Tags for this article:

Monoclonal antibodies
Orphan drugs
Immunosuppressants
Autoimmune diseases
Eculizumab
Myasthenia gravis
Rare diseases
Ravulizumab
Apheresis
Atypical hemolytic uremic syndrome

Click the tags to see associated articles and topics

View Article Details
Safety Considerations for Ravulizumab in NMOSD: Sean Pittock, MD - NeurologyLive

Added to Collection on: 2024-04-23 19:08:11

Tags for this article:

Monoclonal antibodies
Orphan drugs
Autoimmune diseases
Rare diseases
Neuromyelitis optica spectrum disorder
Satralizumab
Inebilizumab
Eculizumab
Multiple sclerosis
Aquaporin-4
Ravulizumab
Therapy

Click the tags to see associated articles and topics

View Article Details
Paroxysmal Nocturnal Hemoglobinuria Market is Expected - openPR.com

Added to Collection on: 2024-05-01 15:57:31

Tags for this article:

Immunosuppressants
Orphan drugs
Hematology
Monoclonal antibodies
Complement system
Pegcetacoplan
Alexion Pharmaceuticals
PNH
Danicopan
Paroxysmal nocturnal hemoglobinuria
Crovalimab
Eculizumab

Click the tags to see associated articles and topics

View Article Details
Ravulizumab Outperforms NMOSD Therapies in Preventing Relapse, Meta-Analysis Reveals

Added to Collection on: 2024-05-14 19:11:40

Tags for this article:

Orphan drugs
Monoclonal antibodies
Neuromyelitis optica spectrum disorder
Inebilizumab
Satralizumab
Eculizumab
Multiple sclerosis
Ravulizumab
Relapse prevention
Aquaporin-4

Click the tags to see associated articles and topics

View Article Details
Reviewing Ravulizumab's Long-Term Profile as New NMOSD Treatment - NeurologyLive

Added to Collection on: 2024-05-18 19:10:46

Tags for this article:

Orphan drugs
Monoclonal antibodies
Neuromyelitis optica spectrum disorder
Satralizumab
Inebilizumab
Eculizumab
Ravulizumab
Multiple sclerosis
Horizon Therapeutics
Genentech

Click the tags to see associated articles and topics

View Article Details
FDA clears Amgen's Bkemv as first biosimilar of Soliris - Pharmaphorum

Added to Collection on: 2024-05-29 21:48:08

Tags for this article:

Orphan drugs
Monoclonal antibodies
Acquired hemolytic anemia
Immunosuppressants
Eculizumab
Hemolytic–uremic syndrome
Paroxysmal nocturnal hemoglobinuria
Ravulizumab
Amgen
Alexion Pharmaceuticals
United States
Soliris

Click the tags to see associated articles and topics

View Article Details
Amgen's rare-disease treatment biosimilar Bkemv gets FDA approval | Morningstar

Added to Collection on: 2024-05-29 10:54:38

Tags for this article:

Acquired hemolytic anemia
Blood disorders
Alexion Pharmaceuticals
AstraZeneca
Nephrology
Eculizumab
Hemolysis
Hemolytic–uremic syndrome
Thrombotic microangiopathy
Hematologic disease
Paroxysmal nocturnal hemoglobinuria
Amgen
Soliris

Click the tags to see associated articles and topics

View Article Details
Two novel biosimilars approved in EU and US - European Pharmaceutical Review

Added to Collection on: 2024-05-29 16:41:40

Tags for this article:

Monoclonal antibodies
Acquired hemolytic anemia
Orphan drugs
Immunosuppressants
Eculizumab
Omalizumab
Alexion Pharmaceuticals
Paroxysmal nocturnal hemoglobinuria
Celltrion
Hemolytic–uremic syndrome
Thrombotic microangiopathy
Hemolysis

Click the tags to see associated articles and topics

View Article Details